Clinical Trials Browser

Phase 3 × Carcinoma, Small Cell × Thoracic × Clear all

NCT03699956 2024-03-26

REPLATINUM

Phase 3 Terminated

Lung Neoplasms, Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT00826644 2021-08-09

COMBAT

Phase 3 Completed

Carcinoma, Small Cell, Small Cell Lung Carcinoma

NCT02688036 2018-01-02

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Phase 3 Unknown

Lung Neoplasms, Carcinoma, Small Cell